section name header

Y-Site Injection Compatibility (1:1 Mixture)

Dihydroergotamine mesylate

(Mfr: PER)(Conc: 4 mcg/mLb)

QMark

Ondansetron HCl

(Mfr: ACD)(Conc: 2 mg/mL)

Remarks:

Inconsistent results from subvisible particle analyses. Microparticulates detected by 2 of 3 methods in 4 hr at 23°Cd

Ref:

3976